Protocols
1 protocol(s) meet the specified criteria
Drug: CAR138 T-cells
Protocol No.TitleStatus
LCCC1603-ATLPhase I Study of the Administration of Autologous CAR-T Cells Targeting the CD138 Antigen for Relapsed / Refractory Multiple MyelomaOpen